{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:33:07Z","timestamp":1787085187957,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.7759\/cureus.114757","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:18:20Z","timestamp":1787084300000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Cannabinoids in Improving Nutritional Outcomes in Chemotherapy Patients: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Omar","family":"Suleiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrithik","family":"Saride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaila","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Balulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Elazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melannie","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Riekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie N","family":"Petrosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/hr\/uhad150","article-title":"Cannabis sativa: origin and history, glandular trichome development, and cannabinoid biosynthesis","volume":"10","author":"Xie Z","year":"2023","unstructured":"Xie Z, Mi Y, Kong L, et al.. Cannabis sativa: origin and history, glandular trichome development, and cannabinoid biosynthesis. Hortic Res. 2023, 10:uhad150. 10.1093\/hr\/uhad150","journal-title":"Hortic Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-022-00438-3","article-title":"Review: cannabinoids as medicinals","volume":"9","author":"Khalsa JH","year":"2022","unstructured":"Khalsa JH, Bunt G, Blum K, Maggirwar SB, Galanter M, Potenza MN. Review: cannabinoids as medicinals. Curr Addict Rep. 2022, 9:630-46. 10.1007\/s40429-022-00438-3","journal-title":"Curr Addict Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1071\/ch21006","article-title":"The chemistry of cannabis and cannabinoids","volume":"74","author":"Duggan PJ","year":"2021","unstructured":"Duggan PJ. The chemistry of cannabis and cannabinoids. Aust J Chem. 2021, 74:369-87. 10.1071\/ch21006","journal-title":"Aust J Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2016.1145794","article-title":"Cannabinoids: medical implications","volume":"48","author":"Schrot RJ","year":"2016","unstructured":"Schrot RJ, Hubbard JR. Cannabinoids: medical implications. Ann Med. 2016, 48:128-41. 10.3109\/07853890.2016.1145794","journal-title":"Ann Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03710-7","article-title":"Cannabinoids in the landscape of cancer","volume":"147","author":"Mangal N","year":"2021","unstructured":"Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH. Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol. 2021, 147:2507-34. 10.1007\/s00432-021-03710-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural basis of selective cannabinoid CB(2) receptor activation","volume":"14","author":"Li X","year":"2023","unstructured":"Li X, Chang H, Bouma J, et al.. Structural basis of selective cannabinoid CB(2) receptor activation. Nat Commun. 2023, 14:1447. 10.1038\/s41467-023-37112-9","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063344","article-title":"Cannabinoids: therapeutic use in clinical practice","volume":"23","author":"Pagano C","year":"2022","unstructured":"Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: therapeutic use in clinical practice. Int J Mol Sci. 2022, 23:10.3390\/ijms23063344","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184360","article-title":"Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study","volume":"12","author":"Pearce A","year":"2017","unstructured":"Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. PLoS One. 2017, 12:e0184360. 10.1371\/journal.pone.0184360","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6377-7","article-title":"Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol","volume":"19","author":"Steinmeyer Z","year":"2019","unstructured":"Steinmeyer Z, G\u00e9rard S, Filleron T, et al.. Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol. BMC Cancer. 2019, 19:1153. 10.1186\/s12885-019-6377-7","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124015","article-title":"Chemotherapy and targeted agents in the treatment of elderly patients with metastatic colorectal cancer","volume":"9","author":"Tuca A","year":"2020","unstructured":"Tuca A, Gallego R, Ghanem I, Gil-Raga M, Feliu J. Chemotherapy and targeted agents in the treatment of elderly patients with metastatic colorectal cancer. J Clin Med. 2020, 9:10.3390\/jcm9124015","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-020-0629-0","article-title":"Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis","volume":"74","author":"Bullock AF","year":"2020","unstructured":"Bullock AF, Greenley SL, McKenzie GA, Paton LW, Johnson MJ. Relationship between markers of malnutrition and clinical outcomes in older adults with cancer: systematic review, narrative synthesis and meta-analysis. Eur J Clin Nutr. 2020, 74:1519-35. 10.1038\/s41430-020-0629-0","journal-title":"Eur J Clin Nutr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00869-z","article-title":"Management of metastatic colorectal carcinoma in older adults: balancing risks and benefits of novel therapies","volume":"38","author":"Correa E","year":"2021","unstructured":"Correa E, Lindsay T, Dotan E. Management of metastatic colorectal carcinoma in older adults: balancing risks and benefits of novel therapies. Drugs Aging. 2021, 38:639-54. 10.1007\/s40266-021-00869-z","journal-title":"Drugs Aging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0187","article-title":"Cannabinoids to improve health-related quality of life in patients with neurological or oncological disease: a meta-analysis","volume":"8","author":"Belgers V","year":"2023","unstructured":"Belgers V, R\u00f6ttgering JG, Douw L, et al.. Cannabinoids to improve health-related quality of life in patients with neurological or oncological disease: a meta-analysis. Cannabis Cannabinoid Res. 2023, 8:41-55. 10.1089\/can.2021.0187","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010074","article-title":"Cannabinoids in treating chemotherapy-induced nausea and vomiting, cancer-associated pain, and tumor growth","volume":"25","author":"Bathula PP","year":"2023","unstructured":"Bathula PP, Maciver MB. Cannabinoids in treating chemotherapy-induced nausea and vomiting, cancer-associated pain, and tumor growth. Int J Mol Sci. 2023, 25:10.3390\/ijms25010074","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgab007","article-title":"Cannabinoids and cancer chemotherapy-associated adverse effects","volume":"2021","author":"Ward SJ","year":"2021","unstructured":"Ward SJ, Lichtman AH, Piomelli D, Parker LA. Cannabinoids and cancer chemotherapy-associated adverse effects. J Natl Cancer Inst Monogr. 2021, 2021:78-85. 10.1093\/jncimonographs\/lgab007","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2864384","article-title":"Medical cannabinoids for cancer cachexia: a systematic review and meta-analysis","volume":"2019","author":"Wang J","year":"2019","unstructured":"Wang J, Wang Y, Tong M, Pan H, Li D. Medical cannabinoids for cancer cachexia: a systematic review and meta-analysis. Biomed Res Int. 2019, 2019:2864384. 10.1155\/2019\/2864384","journal-title":"Biomed Res Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0756-3","article-title":"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study","volume":"10","author":"Farokhnia M","year":"2020","unstructured":"Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry. 2020, 10:71. 10.1038\/s41398-020-0756-3","journal-title":"Transl Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/nutrit\/nuab045","article-title":"Appetite stimulants for\u2002patients with cancer: current evidence for clinical practice","volume":"80","author":"Turcott JG","year":"2022","unstructured":"Turcott JG, Zatarain-Barr\u00f3n ZL, C\u00e1rdenas Fern\u00e1ndez D, Casta\u00f1ares Bola\u00f1os DT, Arrieta O. Appetite stimulants for\u2002patients with cancer: current evidence for clinical practice. Nutr Rev. 2022, 80:857-73. 10.1093\/nutrit\/nuab045","journal-title":"Nutr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgab011","article-title":"The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids","volume":"2021","author":"Sexton M","year":"2021","unstructured":"Sexton M, Garcia JM, Jatoi A, Clark CS, Wallace MS. The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids. J Natl Cancer Inst Monogr. 2021, 2021:86-98. 10.1093\/jncimonographs\/lgab011","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref20","article-title":"JBI Critical Appraisal Tools. Adelaide: University of Adelaide","author":"Joanna Briggs Institute","year":"2020","unstructured":"Joanna Briggs Institute. JBI Critical Appraisal Tools. Joanna Briggs Institute, University of Adelaide, Adelaide, Australia; 2020. https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/BF00256701","article-title":"Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis","volume":"17","author":"Pomeroy M","year":"1986","unstructured":"Pomeroy M, Fennelly JJ, Towers M. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Cancer Chemother Pharmacol. 1986, 17:285-8. 10.1007\/BF00256701","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198508000-00013","article-title":"A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy","volume":"8","author":"Niiranen A","year":"1985","unstructured":"Niiranen A, Mattson K. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Am J Clin Oncol. 1985, 8:336-40. 10.1097\/00000421-198508000-00013","journal-title":"Am J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198708000-00014","article-title":"Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy","volume":"10","author":"Niiranen A","year":"1987","unstructured":"Niiranen A, Mattson K. Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy. Am J Clin Oncol. 1987, 10:325-9. 10.1097\/00000421-198708000-00014","journal-title":"Am J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial","volume":"125","author":"C\u00f4t\u00e9 M","year":"2016","unstructured":"C\u00f4t\u00e9 M, Trudel M, Wang C, Fortin A. Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial. Ann Otol Rhinol Laryngol. 2016, 125:317-24. 10.1177\/0003489415612801","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419881498","article-title":"The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study","volume":"18","author":"Bar-Sela G","year":"2019","unstructured":"Bar-Sela G, Zalman D, Semenysty V, Ballan E. The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study. Integr Cancer Ther. 2019, 18:1534735419881498. 10.1177\/1534735419881498","journal-title":"Integr Cancer Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois TD","year":"2011","unstructured":"Brisbois TD, de Kock IH, Watanabe SM, et al.. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol. 2011, 22:2086-93. 10.1093\/annonc\/mdq727","journal-title":"Ann Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2024.01.031","article-title":"Experience with medical marijuana in a pediatric palliative care clinic: case report","volume":"67","author":"Sahli J","year":"2024","unstructured":"Sahli J, Grossoehme D, Friebert S. Experience with medical marijuana in a pediatric palliative care clinic: case report. J Pain Symptom Manage. 2024, 67:e361-5. 10.1016\/j.jpainsymman.2024.01.031","journal-title":"J Pain Symptom Manage"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001173020302","article-title":"Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine","volume":"302","author":"Sallan SE","year":"1980","unstructured":"Sallan SE, Cronin C, Zelen M, Zinberg NE. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N Engl J Med. 1980, 302:135-8. 10.1056\/NEJM198001173020302","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1847","article-title":"Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group","volume":"24","author":"Strasser F","year":"2006","unstructured":"Strasser F, Luftner D, Possinger K, et al.. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol. 2006, 24:3394-400. 10.1200\/JCO.2005.05.1847","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476813-efficacy-of-cannabinoids-in-improving-nutritional-outcomes-in-chemotherapy-patients-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:18:21Z","timestamp":1787084301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476813-efficacy-of-cannabinoids-in-improving-nutritional-outcomes-in-chemotherapy-patients-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.114757","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}